A L Ehle - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

A L Ehle

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Neurology|July 1, 1982

Plasmapheresis in multiple sclerosis: prospective trial of pheresis and immunosuppression versus immunosuppression aloneR S Tindall, J E Walker, A L Ehle, et al.

Therapeutic Drug Monitoring|September 1, 1990

Evaluation of the Ames Seralyzer for the determination of carbamazepine, phenobarbital, and phenytoin concentrations in salivaM V Miles, M B Tennison, R S Greenwood, et al.

Cancer Treatment Reports|January 1, 1981

Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumorsE A Neuwelt, S A Hill, E P Frenkel, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Neurology|July 1, 1982

Plasmapheresis in multiple sclerosis: prospective trial of pheresis and immunosuppression versus immunosuppression aloneR S Tindall, J E Walker, A L Ehle, et al.

Therapeutic Drug Monitoring|September 1, 1990

Evaluation of the Ames Seralyzer for the determination of carbamazepine, phenobarbital, and phenytoin concentrations in salivaM V Miles, M B Tennison, R S Greenwood, et al.

Cancer Treatment Reports|January 1, 1981

Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumorsE A Neuwelt, S A Hill, E P Frenkel, et al.

Pageof 2